Citigroup
HCAT icon

Citigroup’s Health Catalyst HCAT Stock Holding History

Citigroup’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,000
Closed -$836K – 6398
2022
Q1 		$836K Buy
+32,000
New +$908K ﹤0.01% 3128
2021
Q3 		– Sell
-34,000
Closed -$1.89M – 6008
2021
Q2 		$1.89M Buy
+34,000
New +$1.81M ﹤0.01% 2705

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's HCAT Position: Q2 2026 in Review

Citigroup reduced its Health Catalyst (HCAT) stake by 100% in Q2 2026, selling an estimated $4.28K and leaving 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5627.

Citigroup first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $983K in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Citigroup held 2 shares of Health Catalyst worth $4 as of Q2 2026.
  • Citigroup sold 2,963 Health Catalyst shares in Q2 2026, an estimated $4.28K.
  • Health Catalyst made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5627 holding.
  • Citigroup first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • Citigroup's Health Catalyst position peaked at $983K in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.